Stocks
Arcutis Biotherapeutics (ARQT) R&D/CAPEX US GAAP (year values) |
|||||||||
| 2020 | 2021 | 2021 | 2022 | 2023 | LTM ? | CAGR 5 years ? | |||
| R&D/CAPEX, % | 35 921% | 14 629% | 14 629% | 783.6% | 25 835% | 59 497% | |||
| Changes by years, y/y, % | +23 541pp | -21 293pp | 0pp | -13 845pp | +25 052pp | +20.2% | |||
Arcutis Biotherapeutics. R&D/CAPEX, %
Arcutis Biotherapeutics. R&D/CAPEX, changes, pp
Arcutis Biotherapeutics (ARQT) R&D/CAPEX US GAAP (quarter values) |
||||||||
| 2023Q4 | 2024Q1 | 2024Q1 | 2024Q2 | 2024Q3 | LTM ? | |||
| R&D/CAPEX, % | 396 250% | 13 637% | 59 497% | |||||
| Changes by years, y/y, % | +368 708pp | -43 104pp | -43 104pp | -9 137pp | -27 357pp | |||
| Changes by quarters, q/q, % | +355 256pp | -396 250pp | ||||||
